Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10112730 | 0.87 | HSD11B1 (0.38) | FFAR4HSD11B1HRH3SCN9A | |
| SCHEMBL4719446 | 0.80 | FFAR4 (0.35) | FFAR4HSD11B1HRH3SCN9A | |
| SCHEMBL5631276 | 0.80 | FFAR4 (0.35) | FFAR4HSD11B1HRH3SCN9A | |
| SCHEMBL5630400 | 0.74 | HSD11B1 (0.39) | FFAR4HSD11B1HRH3SCN9A | |
| SCHEMBL4718410 | 0.74 | HSD11B1 (0.39) | FFAR4HSD11B1HRH3SCN9A | |
| SCHEMBL10112648 | 0.74 | HSD11B1 (0.35) | FFAR4HSD11B1 | |
| SCHEMBL10112533 | 0.74 | HSD11B1 (0.35) | FFAR4HSD11B1 | |
| SCHEMBL5630597 | 0.72 | HSD11B1 (0.37) | HSD11B1SCN9A | |
| SCHEMBL5631223 | 0.72 | HSD11B1 (0.37) | HSD11B1SCN9A | |
| SCHEMBL5630592 | 0.72 | HSD11B1 (0.37) | HSD11B1SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8193207-B2 | Lactam compounds and methods of using the same | INCYTE CORPORATION (US) | 2012-06-05 | — | — | US | disclosed |
| US-20070129345-A1 | Lactam compounds and methods of using the same | INCYTE CORPORATION | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129345-A1 | Lactam compounds and methods of using the same | HSD11B1, HSD17B11, HSD17B1 | FFAR4 4151/4885HSD11B1 1/4885HRH3 2940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.